D. Aframian and R. Lalla, Management of dental patients taking common haemostasisaltering medications. Oral Surg. Oral Med. Oral Pathol. Oral Radiol, vol.103, pp.1-11, 2007.

. Agence-nationale-de-sécurité-du-médicament, Bon usage des médicaments antivitamine K (AVK), J. Eur. Urgences Réanimation, vol.24, issue.3, pp.170-179, 2012.

. Agence-nationale-de-sécurité-du-médicament, Bon usage des agents antiplaquettaires, J. Eur. Urgences Réanimation, vol.24, issue.3, pp.180-186, 2012.

. Agence-nationale-de-sécurité-du-médicament, Les anticoagulants en France en 2014 : état des lieux, synthèse et surveillance, Recommandations 1998 : les examens préopératoires systématiques, 2014.

. Disponible,

J. Anderson, .. M. Brewer, A. Creagh, D. Hook, S. Mainwaring et al., Guidance on the dental management of patients with haemophilia and congenital bleeding disorders, Br. Dent. J, vol.215, pp.497-504, 2013.

N. Aoun, Z. Noujem, and S. Toum, von Willebrand Disease Revealed after Dental Postextractional Bleeding: A, J. Int Oral Health, vol.8, pp.512-517, 2016.

L. Ardekian, R. Gasper, M. Peled, and B. Brenner, Does low-dose aspirin therapy complicate oral surgical procedures?, J. Am. Dent. Assoc. JADA, vol.131, issue.3, pp.331-335, 2000.

S. Asirvatham, T. Hu, and V. Vaidya, Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab. Vasc. Health Risk Manag, vol.12, pp.35-44, 2016.

Z. Baghani, Periodontal Dressing: A Review Article, J. Dent. Res. Dent. Clin. Dent. Prospects, vol.7, issue.4, pp.183-191, 2013.

B. V. Bajkin, S. L. Popovic, and S. D. Selakovic, Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth, J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg, vol.67, issue.5, p.990, 2009.

A. Bezeaud, Exploration de la coagulation, Encycl. Méd. Chir, pp.1-3, 2001.

G. Biondi-zoccai, M. Lotrionte, and A. P. , A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease, Eur. Heart J, vol.27, issue.22, pp.2667-2676, 2006.

H. Boukais, W. Zerrouki, F. Daimellah, and A. R. , Antithrombotiques et odontostomatologie. Encycl. Méd Chir, vol.8, issue.3, pp.1-13, 2013.

A. Bouziane, L. Benrachadi, O. Ennibi, L. Abdellaoui, and N. Benzarti, Maladies hématologiques : manifestations parodontales et prise en charge, Rev. Odontostomatol, vol.31, issue.11, pp.299-320, 2002.

A. Brahim, N. Stieltjes, V. Roussel-robert, and F. Yung, Extractions dentaires chez l'enfant présentant une maladie hémorragique constitutionnelle : protocole thérapeutique et résultats, Rev Stomatol Chir Maxillo-Fac, vol.107, issue.5, pp.331-337, 2006.

V. Branislav, M. Ivana, and K. M. , Dental extractions and risk of bleeding in patients taking single and dual antiplatelet treatment, Br. J. Oral Maxillofac. Surg, vol.53, issue.1, pp.39-43, 2015.

O. Breik, A. Cheng, P. Sambrook, and A. Goss, Protocol in managing oral surgical patients taking dabigatran, Aust. Dent. J, vol.59, issue.3, pp.296-301, 2014.

A. K. Brewer, E. M. Roebuck, M. Donachie, A. Hazard, K. Gordon et al., , 2003.

A. W. Budenz, The Importance of Technique Selection for Administration of Local Anesthetics, Contemp. Oral Hyg, vol.7, issue.4, pp.20-27, 2007.

J. Buxeraud, B. La-vitamine, and K. Prat, En Nutr, vol.9, issue.33, pp.39-42, 2013.

J. P. Cambus, V. Simonnet, B. Boneu, and P. Léger, Antivitamines K : utilisation pratique, pp.1-10, 2003.

P. D. Cannon and V. T. Dharmar, Minor oral surgical procedures in patients on oral anticoagulants-a controlled study, Aust. Dent. J, vol.48, issue.2, pp.115-118, 2003.

P. Casais, A. Sánchez-luceros, S. Meschengieser, C. Fondevila, M. T. Santarelli et al., Bleeding risk factors in chronic oral anticoagulation with acenocoumarol, Am. J. Hematol, vol.63, issue.4, pp.192-196, 2000.

S. Chbicheb, F. Hakkou, E. Wady, and W. , Troubles de l'hémostase : manifestations buccales et prise en charge, Encycl. Méd. Chir, vol.8, issue.6, pp.1-8, 2013.

Y. Cohen and J. C. , Anticoagulants. Pharmacologie, vol.6, issue.2, pp.75-78, 2011.

J. Collet, F. Himbert, and P. Steg, Myocardical infaction after aspirin cessation in stable coronary artery disease patients, Int J Cardiol, vol.76, issue.2-3, pp.257-258, 2000.

M. Davarpanah, S. Szmukler-moncler, P. Rajzbaum, and K. Davarpanah, Manuel d'implantologie clinique-3 e édition. Paris: Éditions CdP, vol.680, 2012.

C. Davis, C. Robertson, S. Shivakumar, and L. M. , Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice, J. Can. Dent. Assoc, vol.79, p.74, 2013.

T. De-revel and D. K. , Physiologie de l'hémostase. Encycl. Méd. Chir, vol.9, pp.1-12, 2014.

J. Delobel, Thrombopénies : à l'exception des purpuras thrombopéniques idiopathiques et des purpuras thrombotiques thrombocytopéniques

C. Desconclois and D. M. , Rôle du foie dans l'hémostase, vol.5, p.1, 2010.

P. Dineen, R. Curtin, and J. Harty, A review of the use of common antiplatelet agents in orthopaedic practice, J. Bone Jt. Surg, vol.92, issue.9, pp.1186-1191, 2010.

J. D. Douketis, J. A. Johnson, and T. A. , Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen, Arch. Intern. Med, vol.164, issue.12, pp.1319-1326, 2004.

S. M. Dridi, C. D. Arreto, and D. M. , Chirurgie et hémostase. Réal. Clin, vol.11, issue.2, pp.225-238, 2000.

M. El-abed, A. Rezgui, W. Ben-yahiya, M. Karmani, A. Mzabi et al., Syndrome hémorragique et hypovitaminose K, Rev. Médecine Interne, vol.35, issue.S1, p.171, 2014.

S. Elad, J. Marshall, C. Meyerowitz, and C. G. , Novel anticoagulants: general overview and practical considerations for dental practitioners, Oral Dis, vol.22, issue.1, pp.23-32, 2016.

M. Elbaz, Le rapport bénéfice-risque des nouveaux agents antiagrégants plaquettaires, AMCVP, vol.17, issue.203, pp.27-31, 2011.

E. Orphanet and . La-maladie-de-willebrand, , 2006.

. Disponible,

H. R. Fakhri, S. J. Janket, E. A. Jackson, A. E. Baird, R. Dinnocenzo et al., Tutorial in oral antithrombotic therapy: biology and dental implications, Med. Oral Patol. Oral Cir. Bucal, vol.18, issue.3, pp.461-472, 2013.

S. Faure, Nouveaux anticoagulants oraux, Actual. Pharm, vol.52, issue.525, pp.55-58, 2013.

S. Faure, M. Meliani-pohu, A. Marzellier, and H. Caillemet, L'automesure de l'International normalized ratio (INR), Actual. Pharm, vol.52, issue.522, pp.33-37, 2013.

A. B. Federici, R. Sacco, F. Stabile, M. Carpenedo, E. Zingaro et al., , 2000.

, Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases, Haemoph. Off. J. World Fed. Hemoph, vol.6, pp.71-77

E. Ferrari, M. Benhamou, P. Cerboni, and M. Baudoy, Coronary syndromes following aspirin withdrawal. A special risk for late sent thrombosis, J. Am. Coll. Cardiol, vol.45, issue.3, pp.456-459, 2005.

F. J. Firriolo and W. S. Hupp, Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg. Oral Med. Oral Pathol, Oral Radiol, vol.113, issue.4, pp.431-441, 2012.

M. Franchini and G. Lippi, The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex, Biol. Targets Ther, vol.1, pp.285-289, 2007.

P. Gaussem, A. , and E. , Physiologie et exploration de la fibrinolyse, 2014.

K. Ghadimi, K. E. Dombrowski, J. H. Levy, and I. J. Welsby, Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation, Expert Rev. Hematol, vol.9, issue.2, pp.115-122, 2016.

G. Greenstein and J. Cavallaro, Practical application of anatomy for the dental implant surgeon, J. Periodontol, vol.79, issue.10, pp.1833-1846, 2008.

W. S. Hupp, F. J. Firriolo, and W. T. , Dental clinic advisor. Von Willebrand diseases, vol.550, 2006.

W. S. Hupp, T. Williams, and F. J. Firriolo, Dental clinic advisor. Hemophilia (Types A, B, C), vol.550, 2006.

F. Jobin, . L'hémostase, and . Québec, Presses Université Laval, vol.487, 1995.

C. D. Kalpidis and A. B. Konstantinidis, Critical hemorrhage in the floor of the mouth during implant placement in the first mandibular premolar position: a case report, Implant Dent, vol.14, issue.2, p.117, 2005.

R. Kathariya and H. Jain, To pack or not to pack: the current status of periodontal dressings, J. Appl. Biomater. Funct. Mater, vol.13, issue.2, pp.73-86, 2015.

J. E. Kaufmann, A. Oksche, C. B. Wollheim, G. Günther, W. Rosenthal et al., Vasopressininduced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP, J. Clin. Invest, vol.106, issue.1, pp.107-116, 2000.

M. Kirsch, M. Ginat, L. Lecerf, and R. Houel, Aortic wall alterations after use of gelatinresorcinol-formalin glue, Ann. Thorac. Surg, vol.73, issue.2, pp.642-644, 2002.

M. Krasny and K. Krasny, Safety and efficacy of bone wax in patients on oral anticoagulant therapy, Acta. Pol. Pharm, vol.71, issue.4, pp.683-686, 2014.

P. Kukreja, Haemostatic agents in oral surgery : a brief review, Indian J. Stomatol, 2011.

R. Ladouceur, Utilisation des antifibrinolytiques pour les saignements : un traitement méconnu, Medpal, vol.3, issue.2, pp.71-77, 2008.

F. Laurent, A. Alantar, M. Baranes, F. Bouaziz, N. Davido et al., Risques médicaux : guide de prise en charge par le chirurgien-dentiste, p.135, 2013.

T. Lecompte, E. Ferrari, and P. Nguyen, Médicaments inhibiteurs des fonctions plaquettaires, Sang Thromb. Vaiss, vol.90, issue.11, pp.137-139, 2003.

C. Lesca, S. Boumendjel, M. Boumendjel, M. Hefied, B. Ismail et al., Hémostase locale par membrane enduite de cyanoacrylate, après avulsions dentaires sous anticoagulants ou anti-agrégants, Rev. Stomatol. Chir. Maxillofac, vol.113, issue.3, pp.143-147, 2012.

H. Lévesque and P. J. , Anti-agrégants plaquettaires et anti-vitamine K en stomatologie et chirurgie maxillo-faciale, Rev. Stomatol. Chir. Maxillofac, vol.104, issue.2, pp.80-90, 2003.

T. Lillis, A. Ziakas, K. Koskinas, A. Tsirlis, and G. Giannoglou, Safety of dental extractions during uninterrupted single or dual antiplatelet treatment, Am. J. Cardiol, vol.108, issue.7, pp.964-967, 2011.

O. Mardinger, M. Abba, A. Hirshberg, D. Schwartz-arad, and . Prevalence, diameter and course of the maxillary intraosseous vascular canal with relation to sinus augmentation procedure: a radiographic study, Int. J. Oral Maxillofac. Surg, vol.36, issue.8, pp.735-738, 2007.

W. Mcbee and K. Koerner, Review of hemostatic agents used in dentistry, Dent. Today, vol.24, issue.3, pp.62-65, 2005.

P. Mismetti and L. S. , Rivaroxaban: clinical pharmacology. Ann. Fr. Anesthésie Réanimation, vol.27, issue.3, pp.16-21, 2008.

S. Moliex, S. Pierre, C. Bléry, E. Marret, and H. Beloeil, Examens préinterventionnels systématiques, Ann. Fr. Anesth. Réanimation, vol.31, pp.752-763, 2012.

J. J. Monsuez, M. A. Arnould, and A. J. , Agents antiplaquettaires : les recommandations ANSM/HAS et leur emploi aux urgences, J. Eur. Urgences Réanimation, vol.24, issue.3, pp.177-179, 2012.

P. Moreira, P. M. Filho, E. A. Silva, C. Weksler, S. G. Drable et al., Effect of periodontal treatment on oral anticoagulation in patients with heart disease, Rev. Port. Cardiol. Orgão Of. Soc. Port. Cardiol. Port. J. Cardiol. Off. J. Port. Soc. Cardiol, vol.26, issue.10, pp.977-989, 2007.

Y. Morimoto, H. Niwa, and K. Minematsu, Hemostatic management of tooth extractions in patients on oral antithrombotic therapy, J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg, vol.66, issue.1, pp.51-57, 2008.

Y. Morimoto, H. Niwa, and K. Minematsu, Risk Factors Affecting Postoperative Hemorrhage After Tooth Extraction in Patients Receiving Oral Antithrombotic Therapy, J. Oral Maxillofac. Surg, vol.69, issue.6, pp.1550-1556, 2011.

K. K. Motlagh, I. Loeb, W. Legrand, P. Daelemans, and R. J. , Prévention des saignements postopératoires chez des patients sous anticoagulants oraux, Rev. Stomatol. Chir. Maxillofac, vol.104, issue.2, pp.77-79, 2008.

S. V. Naver, M. Papina, E. J. Solem, and K. P. Dalhoff, Fatal intracerebral haemorrhage possibly caused by interaction between paracetamol and warfarin, Ugeskr. Laeger, vol.177, issue.23, p.121, 2015.

P. Nguyen, N. Hézard, D. , and S. , Explorations de la fonction plaquettaire par cytométrie en flux, vol.9, pp.367-378, 2003.

Y. Nizamaldin and S. J. , Hémostase locale en Chirurgie orale. 2ème partie : efficacité de la colle de fibrine, Med. Buccale Chir. Buccale, vol.18, issue.3, pp.193-210, 2012.
DOI : 10.1051/mbcb/2012005

URL : https://www.mbcb-journal.org/articles/mbcb/pdf/2012/02/mbcb120005.pdf

N. Nooh, W. Abdullah, M. Grawish, S. Ramalingan, F. Javed et al., The effects of surgicel and bone wax hemostatic agents on bone healing: An experimental study, Indian J. Orthop, vol.48, issue.3, pp.319-325, 2014.
DOI : 10.4103/0019-5413.129451

URL : https://doi.org/10.4103/0019-5413.129451

M. Oztürk and I. Ozeç, Utilisation of personal protective equipment in dental practice, Int. Dent. J, vol.53, issue.4, pp.216-219, 2003.

E. Patatanian and S. Fugate, Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction, Ann. Pharmacother, vol.40, issue.12, pp.2205-2210, 2006.
DOI : 10.1345/aph.1h295

A. Peisker, G. F. Raschke, and S. Schultze-mosgau, Management of dental extraction in patients with Haemophilia A and B: A report of 58 extractions, Med. Oral Pathol. Oral Cir. Bucal, vol.19, issue.1, pp.55-60, 2014.

G. Pernod, C. Barro, and F. Blanc-jouvan, Exploration pratique pré-opératoire de l'hémostase, Rev. Stomatol. Chir. Maxillofac, vol.104, issue.2, pp.91-97, 2008.

D. Perrin, V. Ahossi, P. Larras, A. Lafon, and G. E. , Manuel de chirurgie orale : technique de réalisation pratique, maîtrise et exercice raisonné au quotidien

B. Piot, M. Sigaud-fiks, P. Huet, E. Fressinaud, M. Trossaërt et al., Extractions dentaires chez les patients porteurs d'un trouble de l'hémostase. Proposition d'un protocole basé sur le type d'anesthésie, Rev. Stomatol. Chir. Maxillofac, vol.104, issue.2, pp.73-76, 2003.

A. Ramé, La maladie de Willebrand. L'aide-soignante, vol.84, pp.18-19, 2007.

G. Ramström, S. Sindet-pedersen, G. Hall, and M. Blombäck, Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants, J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral Maxillofac. Surg, vol.51, issue.11, pp.1211-1216, 1993.

A. Ranjith and N. K. , Glanzmann thromboasthenia: a rare hematological disorder with oral manifestations: a case report, J. Contemp. Dent. Pr, vol.9, issue.5, pp.107-113, 2008.

J. P. Rerolle, C. Vigneau, A. Hertig, J. Berrou, and R. E. , L'inhibiteur de type 1 des activateurs du plasminogène : physiologie et rôle en physiopathologie rénale, Néphrologie, vol.22, issue.1, pp.5-13, 2001.

Y. Roche, Risques médicaux au cabinet dentaire en pratique quotidienne

K. K. Romond, C. S. Miller, and H. R. , Dental management considerations for a patient taking dabigatran etexilate: a case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol, vol.116, p.191, 2013.
DOI : 10.1016/j.oooo.2013.05.001

G. Rosano, S. Taschieri, J. F. Gaudy, D. Lesmes, D. Fabbro et al., Maxillary Sinus Septa: A Cadaveric Study, J. Oral Maxillofac. Surg, vol.68, issue.6, pp.1360-1364, 2010.
DOI : 10.1016/j.joms.2009.07.069

S. Rose, A. Prevoteau, P. Elzière, D. Hourdet, A. Marcellan et al., Nanoparticle solutions as adhesives for gels and biological tissues, Nature, vol.505, issue.7483, pp.382-385, 2014.
DOI : 10.1038/nature12806

URL : https://hal.archives-ouvertes.fr/hal-01078535

M. Samama, Hémorragies et thromboses. Du diagnostic au traitement

M. Samama and C. Guinet, Laboratory assessment of new anticoagulants, Clin. Chem. Lab. Med, vol.49, issue.5, pp.761-772, 2011.
DOI : 10.1515/cclm.2011.134

M. Samama and I. Elalamy, Maladies hémorragiques acquises et thrombopénies
DOI : 10.1016/b978-2-294-70481-9.50003-8

M. Samama, J. Conard, L. Louët, and A. , Accidents hémorragiques des nouveaux anticoagulants oraux et examens de la coagulation, J. Mal. Vasc, vol.38, issue.4, pp.259-270, 2013.
DOI : 10.1016/j.jmv.2013.05.005

P. Sánchez-palomino, P. Sánchez-cobo, A. Rodriguez-archilla, M. González-jaranay, G. Moreu et al., Dental extraction in patients receiving dual antiplatelet therapy, Med. Oral Patol. Oral Cirugia Bucal, vol.20, issue.5, pp.616-620, 2015.

S. Schulman, C. Kearon, A. K. Kakkar, P. Mismetti, S. Schellong et al., Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism, N. Engl. J. Med, vol.361, issue.24, pp.2342-2352, 2009.
URL : https://hal.archives-ouvertes.fr/ujm-00439704

J. Schved, Traitements de l'hémophilie, EMC-Hématologie, vol.4, pp.1-11, 2009.

R. P. Whitlock, J. C. Sun, S. E. Fremes, F. D. Rubens, K. H. Teoh et al., Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, Chest, vol.141, issue.141, pp.576-600, 2012.

J. Windyga, E. Stefanska-windyga, E. Odnoczko, B. Baran, C. et al., Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors, Haemophilia, vol.22, pp.465-468, 2016.

S. D. Wiviott, E. Braunwald, C. H. Mccabe, G. Montalescot, W. Ruzyllo et al., Prasugrel versus clopidogrel in patients with acute coronary syndromes, N. Engl. J. Med, vol.357, issue.20, pp.2001-2015, 2007.

T. Yilmaz, Accidental cyanoacrylate glue ingestion, Int. J. Pediatr. Otorhinolaryngol, vol.69, issue.6, pp.853-855, 2005.

Q. Zhang, G. Simoneau, C. Verstuyft, L. Drouet, C. B. Sollier et al., Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial, Br. J. Clin. Pharmacol, vol.71, issue.2, pp.232-236, 2011.

R. .. ,

L. .. Des-figures,

L. .. Des-abréviations,

. .. Introduction,

. .. Première-partie-:-rappels,

R. .. Anatomiques,

L. Grande-palatine and .. .. ,

. , 19 1.1.3 Anatomie comparée du maxillaire et de la mandibule

.. .. Obstacles,

R. .. Sur-l'hémostase,

.. .. Hémostase-primaire,

.. .. Déroulement-de-l'hémostase-primaire,

. , 2.2.1.2 Acteurs non cellulaires : les facteurs de coagulation

.. .. Déclenchement-de-l'hémostase-secondaire, 2.2.2.1 Déclenchement de la cascade enzymatique par le facteur tissulaire FT

B. .. De-l'hémostase,

.. .. ,

T. ). ,

. , Exploration de la fibrino-formation

D. .. ,

. .. Actes-sans-risques,

.. .. Actes-À-risque-modéré,

.. .. Actes-À-risque-Élevé,

. , Actes contre-indiqués ou déconseillés en cas de risque hémorragique majoré

F. .. ,

.. .. Facteurs-de-risque, 45 2.2.2 Facteurs de risque hémorragique lié au site chirurgical

T. .. Antithrombotiques,

L. .. Aap), 3.1.1.2 Les thiénopyridines (ticlopidine et clopidogrel)

A. .. , 3.2 Les anticoagulants oraux : antivitamines K (AVK)

A. .. ,

A. .. ,

. , 3.3.1.1 Héparines de bas poids moléculaire (HBPM)

. , Prise en charge des patients traités par héparines

A. ). , Les anticoagulants oraux directs

. , Prise en charge des patients traités par AOD

P. .. De-l'hémostase, , p.61

.. .. Anomalies-de-l'hémostase-primaire,

. , Manifestations buccales des déficits de l'hémostase primaire

. , Prise en charge en cas d'anomalies plaquettaires

.. .. Anomalies-de-la-coagulation-plasmatique,

. , 3 Pathologies hépatiques et déficits de la coagulation

T. .. Orale,

P. Du and . .. Chirurgical,

. .. Techniques-chirurgicales,

. .. Anesthésie,

. .. Compression-locale-immédiate,

P. .. Chimique-de-l'hémostase,

.. .. Hémostatiques,

.. .. Hémostatiques,

.. .. Méthodes-d'hémostase-complémentaires,

A. .. Post-opératoire,

.. .. Survenue-d'une-hémorragie,

Q. .. ,

.. .. ,

, Arbre décisionnel de la prise en charge d'un patient sans risque hémorragique connu, p.97

P. .. ,

A. .. Patients-traités-par, 2.1.2 Arrêt ou maintien du traitement par AAP ?

A. .. Patients-traités-par, 2.2.2 Arrêt ou maintien du traitement par AVK ?

. , 2.3.2 Arrêt ou poursuite du traitement par héparines ?

A. .. Patients-traités-par,

. , Arbre décisionnel de la prise en charge d'un patient porteur d'une anomalie congénitale de l'hémostase

C. .. ,

R. .. Bibliographiques,

, SKLARCYK Thomas-Hémostase en chirurgie orale : guide de bonnes pratiques Nancy 2017 : 135 pages, vol.36

. Th, . Chir, and . Dent, , 2017.

, Mots clés : hémostase, antithrombotiques, recommandations en chirurgie orale Résumé : 'auteur : SKLARCYK Thomas 7, rue Pichon 54000 NANCY Jury: UNIVERSITÉ DE LORRAINE PrésiclenL : C. STRAZIELLE-P rofesseur des Universités Faculté (~· d' Odontologie Juges

. Pt'éseotée-par, i\1Ionsieu1· S KLARCYK Thomas né(e) à: tv.CETZ (iVIosell e) le 03 a vri, p.11991

, H émostase en cbintrgle or ale : guid e d e bonnes pratiques»

C. Le-p-rés-ident-du-j-ury and . Strazielle,

. Autorise-À-soutenir, ~. Imprimer-la-thèse-3, L. A. Nancy, J. ?-:j.m, and L. , Unlversitê de Lormi.na-2'+.30 rua Uonnofs BP GO 120 !i4003 N !àt1 ey Cerle